Skip to main content
Subscribe
  • Sign Up Free
  • Login
  • Subscribe
  • News
    • Current News
    • Providers
    • Insurance
    • Government
    • Finance
    • Technology
    • Safety & Quality
    • Digital Health
    • Transformation
    • ESG
    • People
    • Regional News
    • Digital Edition (Web Version)
    • Patients
    • Operations
    • Care Delivery
    • Payment
    • Midwest
    • Northeast
    • South
    • West
  • Opinion
    • Bold Moves
    • Breaking Bias
    • Commentaries
    • Letters
    • Vital Signs Blog
    • From the Editor
  • Events & Awards
    • Awards
    • Conferences
    • Galas
    • Virtual Briefings
    • Webinars
    • Nominate/Eligibility
    • 100 Most Influential People
    • 50 Most Influential Clinical Executives
    • Best Places to Work in Healthcare
    • Excellence in Governance
    • Health Care Hall of Fame
    • Healthcare Marketing Impact Awards
    • Top 25 Emerging Leaders
    • Top Innovators
    • Diversity in Healthcare
      • - Luminaries
      • - Top 25 Diversity Leaders
      • - Leaders to Watch
    • Women in Healthcare
      • - Luminaries
      • - Top 25 Women Leaders
      • - Women to Watch
    • Digital Health Transformation Summit
    • ESG: The Implementation Imperative Summit
    • Leadership Symposium
    • Social Determinants of Health Symposium
    • Women Leaders in Healthcare Conference
    • Best Places to Work Awards Gala
    • Health Care Hall of Fame Gala
    • Top 25 Diversity Leaders Gala
    • Top 25 Women Leaders Gala
    • - Hospital of the Future
    • - Value Based Care
    • - Hospital at Home
    • - Workplace of the Future
    • - Digital Health
    • - Future of Staffing
    • - Hospital of the Future (Fall)
  • Multimedia
    • Podcast - Beyond the Byline
    • Sponsored Podcast - Healthcare Insider
    • Video Series - The Check Up
    • Sponsored Video Series - One on One
  • Data Center
    • Data Center Home
    • Hospital Financials
    • Staffing & Compensation
    • Quality & Safety
    • Mergers & Acquisitions
    • Data Archive
    • Resource Guide: By the Numbers
    • Surveys
    • Data Points
  • Newsletters
  • MORE+
    • Contact Us
    • Advertise
    • Media Kit
    • Jobs
    • People on the Move
    • Reprints & Licensing
MENU
Breadcrumb
  1. Home
  2. Safety & Quality
June 29, 2013 01:00 AM

Low risk, high cost

Advanced prostate treatment not always beneficial

Andis Robeznieks
  • Tweet
  • Share
  • Share
  • Email
  • More
    Reprints Print
    Researchers say a growing number of men are getting robotic surgery for prostate cancer even when the cancer is low risk or they're more likely to die from another cause.

    The old joke in healthcare research is that nearly every study concludes that more studies are needed. But two new studies on the high cost of low-benefit prostate cancer treatments support that humorous observation.

    In one study, published in the Journal of the American Medical Association, researchers found that men with prostate cancer who were at low risk for dying from that condition or were at high risk of dying from other causes received an increasing number of advanced-treatment technologies such as intensity-modulated radiotherapy and robotic prostatectomies.

    In a study published in the Annals of Internal Medicine, researchers found that keeping close watch on low-risk prostate cancers in men aged 65 and older rather than initiating radiation or surgical treatment prolonged life expectancy by two months longer than the more advanced treatments and was $10,900 to $24,200 cheaper.

    “Aggressive direct-to-consumer marketing and incentives associated with fee-for-service payment may promote the use of these advanced-treatment technologies,” the JAMA report stated. The authors also noted that the increased use of intensity-modulated radiotherapy, or IMRT, and robotic prostatectomy could largely be explained because they were replacements for other therapies such as external beam radiation treatment, or EBRT, and open radical prostatectomy. The authors noted that startup costs for IMRT and robotic surgery facilities are close to $2 million.

    Dr. Ralph Weichselbaum, chairman of radiation and cellular oncology for University of Chicago Medicine, said the authors may be understating the issue. “Doctors are doing a lot of expensive, unnecessary stuff—that seems to be the take-home message,” he said.

    The Annals of Internal Medicine study offered a similar message. “Mounting evidence suggests that many men with localized, low-risk prostate cancer are treated unnecessarily at substantial personal and societal cost,” the report stated. Its authors estimated that if the number of men with newly diagnosed low-risk prostate cancer who selected a “watchful waiting” observation strategy increased to 50% from 10%, it would result in cost savings of $1 billion.

    The increases in procedures using advanced-treatment technologies cited in the JAMA study were recorded between 2004 and 2009. Weichselbaum said he thought the data were still relevant and doubted whether more recent figures would be significantly different. But Dr. R. Jeffrey Karnes, an associate professor of urology with the Mayo Clinic's Graduate School of Medicine in Rochester, Minn., thought otherwise.

    Karnes said fewer prostatectomies were being done at Mayo. But he also noted that most prostatectomies are done robotically now, so it's not surprising that the number of these operations among men with low risk of prostate cancer death is increasing because the numbers are increasing in general. Statistics aside, Karnes said he thought economics were responsible for part of the increase.

    “Hospitals have an underlying pressure to use the technology,” he said.

    While the term “watchful waiting” may seem benign, the perceived passivity of this approach can cause many men to experience great anxiety and lead them to undergo procedures whose benefits may be dubious just because they feel the need to take action. Because of this, patient choice—perhaps driven by hospital marketing—is a factor in the increase of expensive treatments. Karnes said some patients are averse to radiation while others avoid surgery. Many seek to avoid unpleasant prostate cancer-related conditions they saw a friend or relative experience.

    The JAMA report said some experts have suggested that, to ease this anxiety, low-risk tumors be called something besides “cancer.”

    Karnes said he's heard the term “premalignancy” suggested, but he said more than a change of terminology is needed.

    “We have to do a better job of allaying that fear,” Karnes said, adding that psychological help to deal with anxiety could be one method. Better diagnostic and prognostic tools also are needed, as current biopsy tests can only go so far in determining the aggressiveness of a tumor. He said better imaging and genetic tests could go a long way to meet this challenge.

    Dr. Charles Cutler, chairman of the American College of Physicians Board of Regents, said the treatment decisions examined in these studies often begin with discussion in the primary-care physician's office.

    “This is something that I deal with all the time—conversations with men who have been diagnosed with low-risk prostate cancer. The word 'cancer' dominates the conversations,” Cutler said. “It's part of our culture that people don't like the idea of actually waiting with cancer. Certainly the literature supports that watchful waiting is the right thing to do. But the psychology of the situation makes watchful waiting hard to do.”

    Follow Andis Robeznieks on Twitter: @MHARobeznieks

    Letter
    to the
    Editor

    Send us a letter

    Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.

    Recommended for You
    22--Targeted-Cancer-Therapies_edit copy_i.png
    US chemotherapy shortage is leading to treatment complications, cancer centers say
    Racial disparity hospital
    Health, safety disparities persist in highly rated hospitals: Leapfrog Group
    Most Popular
    1
    More healthcare organizations at risk of credit default, Moody's says
    2
    Centene fills out senior executive team with new president, COO
    3
    SCAN, CareOregon plan to merge into the HealthRight Group
    4
    Blue Cross Blue Shield of Michigan unveils big push that lets physicians take on risk, reap rewards
    5
    Bright Health weighs reverse stock split as delisting looms
    Sponsored Content
    Get Newsletters

    Sign up for enewsletters and alerts to receive breaking news and in-depth coverage of healthcare events and trends, as they happen, right to your inbox.

    Subscribe Today
    MH Magazine Cover

    MH magazine offers content that sheds light on healthcare leaders’ complex choices and touch points—from strategy, governance, leadership development and finance to operations, clinical care, and marketing.

    Subscribe
    Connect with Us
    • LinkedIn
    • Twitter
    • Facebook
    • RSS

    Our Mission

    Modern Healthcare empowers industry leaders to succeed by providing unbiased reporting of the news, insights, analysis and data.

    Contact Us

    (877) 812-1581

    Email us

     

    Resources
    • Contact Us
    • Advertise with Us
    • Ad Choices Ad Choices
    • Sitemap
    Editorial Dept
    • Submission Guidelines
    • Code of Ethics
    • Awards
    • About Us
    Legal
    • Terms and Conditions
    • Privacy Policy
    • Privacy Request
    Modern Healthcare
    Copyright © 1996-2023. Crain Communications, Inc. All Rights Reserved.
    • News
      • Current News
      • Providers
      • Insurance
      • Government
      • Finance
      • Technology
      • Safety & Quality
      • Digital Health
      • Transformation
        • Patients
        • Operations
        • Care Delivery
        • Payment
      • ESG
      • People
      • Regional News
        • Midwest
        • Northeast
        • South
        • West
      • Digital Edition (Web Version)
    • Opinion
      • Bold Moves
      • Breaking Bias
      • Commentaries
      • Letters
      • Vital Signs Blog
      • From the Editor
    • Events & Awards
      • Awards
        • Nominate/Eligibility
        • 100 Most Influential People
        • 50 Most Influential Clinical Executives
        • Best Places to Work in Healthcare
        • Excellence in Governance
        • Health Care Hall of Fame
        • Healthcare Marketing Impact Awards
        • Top 25 Emerging Leaders
        • Top Innovators
        • Diversity in Healthcare
          • - Luminaries
          • - Top 25 Diversity Leaders
          • - Leaders to Watch
        • Women in Healthcare
          • - Luminaries
          • - Top 25 Women Leaders
          • - Women to Watch
      • Conferences
        • Digital Health Transformation Summit
        • ESG: The Implementation Imperative Summit
        • Leadership Symposium
        • Social Determinants of Health Symposium
        • Women Leaders in Healthcare Conference
      • Galas
        • Best Places to Work Awards Gala
        • Health Care Hall of Fame Gala
        • Top 25 Diversity Leaders Gala
        • Top 25 Women Leaders Gala
      • Virtual Briefings
        • - Hospital of the Future
        • - Value Based Care
        • - Hospital at Home
        • - Workplace of the Future
        • - Digital Health
        • - Future of Staffing
        • - Hospital of the Future (Fall)
      • Webinars
    • Multimedia
      • Podcast - Beyond the Byline
      • Sponsored Podcast - Healthcare Insider
      • Video Series - The Check Up
      • Sponsored Video Series - One on One
    • Data Center
      • Data Center Home
      • Hospital Financials
      • Staffing & Compensation
      • Quality & Safety
      • Mergers & Acquisitions
      • Data Archive
      • Resource Guide: By the Numbers
      • Surveys
      • Data Points
    • Newsletters
    • MORE+
      • Contact Us
      • Advertise
      • Media Kit
      • Jobs
      • People on the Move
      • Reprints & Licensing